ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Takeda Data at ISTH 2021 Highlight the Benefits of Prophylaxis for Patients with Rare Bleeding Disorders
July 21, 2021Takeda Pharmaceutical Company Limited today announced the results of a phase 3 trial investigating the efficacy and safety of recombinant von Willebrand factor (rVWF) prophylaxis,1 one of the 12 abstracts being presented at the International Society. -
World Thrombosis Day Empowers People Around the World to Recognize and Help Prevent Life-Threatening Blood Clots
October 11, 2019On October 13, the World Thrombosis Day campaign shares an important message: patients, regardless of where they live ... -
ISTH Announces Launch Of New Global Education Initiative In Gene Therapy For Hemophilia
July 08, 2019The International Society on Thrombosis and Haemostasis (ISTH) is pleased to announce the official launch of Gene Therapy in Hemophilia: An ISTH Education Initiative.
Pharma Sources Insight January 2025
